SPTSSA facilitates gastric cancer progression with modulating PD-L1 in immunomicroenvironment through Wnt/β-catenin pathway
SPTSSA promotes GC progression by modulating PD-L1 expression in immunomicroenvironment via the Wnt signaling pathway. Consequently, SPTSSA emerges as a promising new prognostic indicator and a potential therapeutic target for GC management.
Authors
- Xiaoxia Jin (ORCID: https://orcid.org/0000-0002-2388-5281)
- Qiang Xu (ORCID: https://orcid.org/0000-0002-3530-9855)
- Lizhou Jia (ORCID: https://orcid.org/0000-0003-0645-1868)
- Xiaoling Kuai
- Ping‐Ping Sun (ORCID: https://orcid.org/0000-0002-2772-2631)
- Lei Yang (ORCID: https://orcid.org/0000-0002-1133-9099)
- Han Wu (ORCID: https://orcid.org/0000-0002-7418-2930)
- Jianfei Huang (ORCID: https://orcid.org/0000-0002-1276-5962)
- Yao Wang (ORCID: https://orcid.org/0000-0002-4215-6092)
- Xiaojing Zhang (ORCID: https://orcid.org/0000-0003-1795-4399)
- Hang Yin (ORCID: https://orcid.org/0000-0001-9146-0747)
- Haiyan Xu
- Weiwei Qin
Institutions
- Nantong University (CN)
- Affiliated Hospital of Nantong University (CN)
- Nantong Tumor Hospital (CN)
- Anyang Hospital of Traditional Chinese Medicine (CN)
- Inner Mongolia Medical University (CN)
Publication Details
- Journal
- Cellular Oncology
- Published
- 2025-06-11
- DOI
- https://doi.org/10.1007/s13402-025-01072-7
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China